Malignant Diseases — Introduction
The use of thermography in malignant diseases has been confined almost exclusively to breast cancer. Since the early experimental work in 1957 by Lawson of Montreal, followed three years later by that of Lloyd Williams in London, the appreciation of the place of thermography in breast cancer has had many ups and downs. It has been greeted by some with great enthusiasm, while others have considered it to be of no value and many just have not understood its significance at all. Unfortunately, these three factions still exist.